A study to compare the efficacy of two drugs on the success of assisted reproductive therapy in women with polycystic ovarian syndrome and undergoing treatment with IVF

Randomised Control Trial comparing the effects of Metformin to Myoinositol on ART outcome in women with PCOS undergoing IVF cycles

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014196

Enrollment

100

Registered

2018-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PCOS PATIENTS UNDERGOING IVF

Interventions

Intervention1: Myoinositol: Currently the most widely used insulin-sensitizing drugs is metformin as it causes reduction of total and free testosterone concentrations and gives good outcome. The Cochr

Eligibility

Inclusion criteria

Inclusion criteria: ALL PCOS WOMEN RECRUITED FOR IVF

Exclusion criteria

Exclusion criteria: ENDOMETRIOSIS ANY CONDITIONS COMPROMISING IMPLANTATION LIKE FIBROID OVARIAN SURGERY DERRANGED LFTs, KFTs HYPERSENSITIVITY TO MYOINOSITOL WOMEN WITH UNCONTROLLED THYROID DISEASE PATIENTS UNDERGOING FROZEN EMBRYO TRANSFER

Design outcomes

Primary

Measure	Time frame
PERCENTAGE OF WOMEN DEVELOPING OHSS PREGNANCY RATESTimepoint: 2 YEARS	—

Secondary

Measure	Time frame
ART OUTCOMES BIOCHEMICAL AND HARMONAL OUTCOMESTimepoint: 2 YEARS	—

Countries

India

Contacts

Public ContactNEENA MALHOTRA

AIIMS

malhotraneena@yahoo.com9891557707

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 21, 2026